La Clinica terapeutica
-
La Clinica terapeutica · Mar 1998
Clinical Trial[Phase II study of docetaxel in patients with advanced stage soft tissue sarcoma].
To evaluate the activity and toxicity of docetaxel (TXT) as second line therapy in advanced soft-tissue sarcoma. ⋯ The results of this study do not suggest the use of TXT at this dosage and schedule in advanced soft tissue sarcoma.